{"id":1220,"date":"2020-10-02T09:00:00","date_gmt":"2020-10-02T09:00:00","guid":{"rendered":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2020\/09\/28\/dupilumab-treatment-ameliorates-clinical-and-hematological-symptoms-including-blood-eosinophilia-in-patients-with-atopic-dermatitis\/"},"modified":"2020-10-02T19:01:03","modified_gmt":"2020-10-02T19:01:03","slug":"dupilumab-treatment-ameliorates-clinical-and-hematological-symptoms-including-blood-eosinophilia-in-patients-with-atopic-dermatitis","status":"publish","type":"post","link":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2020\/10\/02\/dupilumab-treatment-ameliorates-clinical-and-hematological-symptoms-including-blood-eosinophilia-in-patients-with-atopic-dermatitis\/","title":{"rendered":"Dupilumab treatment ameliorates clinical and hematological symptoms, including blood eosinophilia, in patients with atopic dermatitis."},"content":{"rendered":"<p>Atopic dermatitis (AD) is an allergic disease that affects individuals of various ages. Recently, the IL-4\/13 inhibitor dupilumab has gained regulatory approval for clinical use in AD patients. Dupilumab has [&#8230;]\n","protected":false},"excerpt":{"rendered":"<p>Atopic dermatitis (AD) is an allergic disease that affects individuals of various ages. Recently, the IL-4\/13 inhibitor dupilumab has gained regulatory approval for clinical use in AD patients. Dupilumab has &#8230;<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[86],"tags":[],"acf":[],"_links":{"self":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/1220"}],"collection":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/comments?post=1220"}],"version-history":[{"count":1,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/1220\/revisions"}],"predecessor-version":[{"id":1348,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/1220\/revisions\/1348"}],"wp:attachment":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media?parent=1220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/categories?post=1220"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/tags?post=1220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}